For laboratory research use only — not for human or veterinary use. Not evaluated by the U.S. FDA.
Cellular Peptide
AOD-9604
A 15-amino-acid fragment derived from human growth hormone, examined in animal studies for its effects on fat metabolism and lipolytic signaling.
Size
Quantity
$29.99
Bundle & save
Delivery
Order by 3:00 PM ET for same-day dispatch
Cutoff 3:00 PM ET · same-day dispatch
Estimated arrival in 2–3 business days
Overnight shipping available
Free shipment protection included
AOD-9604
1 × 2mg · $29.99
99% purity, QC passed
HPLC + mass-spec verified
Shipment protection
Free on every order
Free shipping over $150
Same-day dispatch before 3PM ET
Certificate of Analysis
Third-party tested · Independent analytical lab
5mg
99.78%latest
| Tested | Measured | Purity |
|---|---|---|
| Jul 2026 | 5.20mg | 99.78% |
| Jun 2026 | 5.21mg | 99.71% |
| Apr 2026 | 5.65mg | 99.72% |
| Feb 2026 | 5.84mg | 99.08% |
| Nov 2025 | 5.13mg | 99.33% |
| Oct 2025 | 4.92mg | 99.33% |
Frequently researched together
Commonly studied alongside AOD-9604.
Compound information
Technical specifications
Molecular profile
| Type | Modified peptide fragment |
| Molecular weight | ~1,815 g/mol |
| Amino acids | 15 |
| Sequence | Tyr-hGH(177-191) |
Storage & stability
- ❄️
Lyophilized (powder)
-20°C · stable 2+ years
- ❄️
Reconstituted
2–8°C · use within 30 days
Sources & references
Peer-reviewed literature, for research context
- Endocrinology
The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice
2001·DOI: 10.1210/endo.142.12.8522·PMID: 11713213Heffernan M et al.
View source - Annals of Clinical & Laboratory Science
Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model
2015·PMID: 26275694Kwon DR et al.
View source - Journal of Endocrinology and Metabolism
Safety and Tolerability of the Hexadecapeptide AOD9604 in Humans
2013Stier H et al.
View source - Journal of Endocrinology and Metabolism
Safety and Metabolism of AOD9604, a Novel Nutraceutical Ingredient for Improved Metabolic Health
2014Stier H et al.
View source - ASX Announcement
Phase 2B OPTIONS Study Results
2007Metabolic Pharmaceuticals
View source - Hormone Research
Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormone
2000·DOI: 10.1159/000053183·PMID: 11146367Ng FM et al.
View source
Important research notice
Not for human consumption. This product is sold exclusively for laboratory and in vitro research. It is not intended to diagnose, treat, cure, or prevent any disease.
Any research findings referenced on this page are drawn from published, peer-reviewed literature and are provided for educational context only. They are not product claims and should not be read as medical advice.
By purchasing, you confirm you are a qualified researcher and will handle this material in accordance with all applicable laws and institutional guidelines.